Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 29.22
+0.72 (2.53%)
Aug 15, 2025, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 12.56 billion as of August 15, 2025. Its market cap has decreased by -4.95% in one year.
Market Cap
12.56B
Enterprise Value
10.50B
Revenue
2.84B
Ranking
n/a
PE Ratio
15.36
Stock Price
29.22
Market Cap Chart
Since April 30, 2015, HKG:6826's market cap has increased from 9.34B to 12.56B, an increase of 34.42%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 12.58B | -5.72% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | 16.57B | 5.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |